Cargando…

Establishing a clinical service to prevent psychosis: What, how and when? Systematic review

The first rate-limiting step to successfully translate prevention of psychosis in to clinical practice is to establish specialised Clinical High Risk for Psychosis (CHR-P) services. This study systematises the knowledge regarding CHR-P services and provides guidelines for translational implementatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar de Pablo, Gonzalo, Estradé, Andrés, Cutroni, Marcello, Andlauer, Olivier, Fusar-Poli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807021/
https://www.ncbi.nlm.nih.gov/pubmed/33441556
http://dx.doi.org/10.1038/s41398-020-01165-x
_version_ 1783636655276556288
author Salazar de Pablo, Gonzalo
Estradé, Andrés
Cutroni, Marcello
Andlauer, Olivier
Fusar-Poli, Paolo
author_facet Salazar de Pablo, Gonzalo
Estradé, Andrés
Cutroni, Marcello
Andlauer, Olivier
Fusar-Poli, Paolo
author_sort Salazar de Pablo, Gonzalo
collection PubMed
description The first rate-limiting step to successfully translate prevention of psychosis in to clinical practice is to establish specialised Clinical High Risk for Psychosis (CHR-P) services. This study systematises the knowledge regarding CHR-P services and provides guidelines for translational implementation. We conducted a PRISMA/MOOSE-compliant (PROSPERO-CRD42020163640) systematic review of Web of Science to identify studies until 4/05/2020 reporting on CHR-P service configuration, outreach strategy and referrals, service user characteristics, interventions, and outcomes. Fifty-six studies (1998–2020) were included, encompassing 51 distinct CHR-P services across 15 countries and a catchment area of 17,252,666 people. Most services (80.4%) consisted of integrated multidisciplinary teams taking care of CHR-P and other patients. Outreach encompassed active (up to 97.6%) or passive (up to 63.4%) approaches: referrals came mostly (90%) from healthcare agencies. CHR-P individuals were more frequently males (57.2%). Most (70.6%) services accepted individuals aged 12–35 years, typically assessed with the CAARMS/SIPS (83.7%). Baseline comorbid mental conditions were reported in two-third (69.5%) of cases, and unemployment in one third (36.6%). Most services provided up to 2-years (72.4%), of clinical monitoring (100%), psychoeducation (81.1%), psychosocial support (73%), family interventions (73%), individual (67.6%) and group (18.9%) psychotherapy, physical health interventions (37.8%), antipsychotics (87.1%), antidepressants (74.2%), anxiolytics (51.6%), and mood stabilisers (38.7%). Outcomes were more frequently ascertained clinically (93.0%) and included: persistence of symptoms/comorbidities (67.4%), transition to psychosis (53.5%), and functional status (48.8%). We provide ten practical recommendations for implementation of CHR-P services. Health service knowledge summarised by the current study will facilitate translational efforts for implementation of CHR-P services worldwide.
format Online
Article
Text
id pubmed-7807021
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78070212021-01-21 Establishing a clinical service to prevent psychosis: What, how and when? Systematic review Salazar de Pablo, Gonzalo Estradé, Andrés Cutroni, Marcello Andlauer, Olivier Fusar-Poli, Paolo Transl Psychiatry Review Article The first rate-limiting step to successfully translate prevention of psychosis in to clinical practice is to establish specialised Clinical High Risk for Psychosis (CHR-P) services. This study systematises the knowledge regarding CHR-P services and provides guidelines for translational implementation. We conducted a PRISMA/MOOSE-compliant (PROSPERO-CRD42020163640) systematic review of Web of Science to identify studies until 4/05/2020 reporting on CHR-P service configuration, outreach strategy and referrals, service user characteristics, interventions, and outcomes. Fifty-six studies (1998–2020) were included, encompassing 51 distinct CHR-P services across 15 countries and a catchment area of 17,252,666 people. Most services (80.4%) consisted of integrated multidisciplinary teams taking care of CHR-P and other patients. Outreach encompassed active (up to 97.6%) or passive (up to 63.4%) approaches: referrals came mostly (90%) from healthcare agencies. CHR-P individuals were more frequently males (57.2%). Most (70.6%) services accepted individuals aged 12–35 years, typically assessed with the CAARMS/SIPS (83.7%). Baseline comorbid mental conditions were reported in two-third (69.5%) of cases, and unemployment in one third (36.6%). Most services provided up to 2-years (72.4%), of clinical monitoring (100%), psychoeducation (81.1%), psychosocial support (73%), family interventions (73%), individual (67.6%) and group (18.9%) psychotherapy, physical health interventions (37.8%), antipsychotics (87.1%), antidepressants (74.2%), anxiolytics (51.6%), and mood stabilisers (38.7%). Outcomes were more frequently ascertained clinically (93.0%) and included: persistence of symptoms/comorbidities (67.4%), transition to psychosis (53.5%), and functional status (48.8%). We provide ten practical recommendations for implementation of CHR-P services. Health service knowledge summarised by the current study will facilitate translational efforts for implementation of CHR-P services worldwide. Nature Publishing Group UK 2021-01-13 /pmc/articles/PMC7807021/ /pubmed/33441556 http://dx.doi.org/10.1038/s41398-020-01165-x Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review Article
Salazar de Pablo, Gonzalo
Estradé, Andrés
Cutroni, Marcello
Andlauer, Olivier
Fusar-Poli, Paolo
Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
title Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
title_full Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
title_fullStr Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
title_full_unstemmed Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
title_short Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
title_sort establishing a clinical service to prevent psychosis: what, how and when? systematic review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807021/
https://www.ncbi.nlm.nih.gov/pubmed/33441556
http://dx.doi.org/10.1038/s41398-020-01165-x
work_keys_str_mv AT salazardepablogonzalo establishingaclinicalservicetopreventpsychosiswhathowandwhensystematicreview
AT estradeandres establishingaclinicalservicetopreventpsychosiswhathowandwhensystematicreview
AT cutronimarcello establishingaclinicalservicetopreventpsychosiswhathowandwhensystematicreview
AT andlauerolivier establishingaclinicalservicetopreventpsychosiswhathowandwhensystematicreview
AT fusarpolipaolo establishingaclinicalservicetopreventpsychosiswhathowandwhensystematicreview